000 | 01225 a2200325 4500 | ||
---|---|---|---|
005 | 20250517191950.0 | ||
264 | 0 | _c20180222 | |
008 | 201802s 0 0 eng d | ||
022 | _a1744-7658 | ||
024 | 7 |
_a10.1080/13543784.2018.1417385 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEvangelista, Elisa | |
245 | 0 | 0 |
_aUpdate on treatment for idiopathic hypersomnia. _h[electronic resource] |
260 |
_bExpert opinion on investigational drugs _cFeb 2018 |
||
300 |
_a187-192 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aCentral Nervous System Stimulants _xtherapeutic use |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 |
_aGABA-A Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIdiopathic Hypersomnia _xdrug therapy |
650 | 0 | 4 | _aOff-Label Use |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aWakefulness-Promoting Agents _xtherapeutic use |
700 | 1 | _aLopez, Régis | |
700 | 1 | _aDauvilliers, Yves | |
773 | 0 |
_tExpert opinion on investigational drugs _gvol. 27 _gno. 2 _gp. 187-192 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/13543784.2018.1417385 _zAvailable from publisher's website |
999 |
_c27899190 _d27899190 |